Definitive Healthcare names Carrie Lazorchak as CRO; Mirisola to depart Dec 31

Definitive Healthcare Corp.

CRO Joe Mirisola resigns effective Nov 1, 2023; remains Senior Advisor through Dec 31, 2023.
Separation agreement provides 9 months base salary, 2023 bonus, COBRA, and equity acceleration.
Carrie Lazorchak appointed CRO effective Nov 1, 2023; formerly CRO at SimilarWeb.
Mirisola, first employee hired in 2011, helped grow revenue from $0 to $240M.
Lazorchak will lead sales organization to expand client base and drive operational excellence.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Joseph Mirisola

Senior Advisor

DH · Definitive Healthcare Corp.

Effective: 2023-11-01
Filed: October 5, 2023, 7:59 PM ET

In addition, Mr. Mirisola will cease to be Chief Revenue Officer effective November 1, 2023 and will, at such time, become a Senior Advisor.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Mirisola was appointed as Senior Advisor at Definitive Healthcare Corp..

Action: appointed
Role: Senior Advisor

Exact text from the filing

In addition, Mr. Mirisola will cease to be Chief Revenue Officer effective November 1, 2023 and will, at such time, become a Senior Advisor.

View on SEC.gov

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0000950170-23-052203

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.